Displaying One Session

Poster Area (Hall 4) Poster Display session
Date
29.09.2019
Time
12:00 - 13:00
Location
Poster Area (Hall 4)
Poster Display session Poster Display session

Breast cancer, early stage (ID 6626)

Lecture Time
12:00 - 12:00
Speakers
  • Aleix Prat (Barcelona, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

186P - Efficacy of dose-dense (DD) adjuvant chemotherapy (CT) in hormone receptor positive/HER2-negative early breast cancer (BC) patients (pts) according to immunohistochemically (IHC) defined luminal subtypes: an exploratory analysis of the GIM2 trial. (ID 2551)

Presentation Number
186P
Lecture Time
12:00 - 12:00
Speakers
  • Benedetta Conte (Genova, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

187P - High dose Neo-adjuvant chemotherapy in Triple-Negative breast cancer with evidence of homologous recombination deficiency (HRD). (ID 3426)

Presentation Number
187P
Lecture Time
12:00 - 12:00
Speakers
  • Sonja B. Vliek (Amsterdam, Netherlands)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

188P - Risk factors for locoregional recurrence (LRR) after neoadjuvant chemotherapy: pooled analysis of prospective neoadjuvant breast cancer (BC) trials (ID 3792)

Presentation Number
188P
Lecture Time
12:00 - 12:00
Speakers
  • Gustavo Werutsky (Porto Alegre, Brazil)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

189P - Estimating radiotherapy-induced cardiovascular mortality in female breast cancer patients. (ID 4044)

Presentation Number
189P
Lecture Time
12:00 - 12:00
Speakers
  • Mark De Ridder (Brussels, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

190P - 3-year follow-up of a phase III trial comparing the efficacy and safety of neoadjuvant and adjuvant trastuzumab and its biosimilar CT-P6 in HER2 positive early breast cancer (EBC) (ID 719)

Presentation Number
190P
Lecture Time
12:00 - 12:00
Speakers
  • Justin Stebbing (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

191P - Adjuvant chemotherapy in elderly breast cancer patients: pattern of use and impact on overall survival (ID 3595)

Presentation Number
191P
Lecture Time
12:00 - 12:00
Speakers
  • Axel Berthelot (Marseille, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

192P - Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): a propensity score-matched study. (ID 3992)

Presentation Number
192P
Lecture Time
12:00 - 12:00
Speakers
  • Maria Vittoria Dieci (Padova, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

193P - Impact of adjuvant trastuzumab emtansine (T-DM1) on incidence of metastatic breast cancer (mBC): an epidemiological model of patients with HER2-positive breast cancer (BC) who did not achieve pathological complete response (pCR) after neoadjuvant treatment (non-pCR) (ID 3477)

Presentation Number
193P
Lecture Time
12:00 - 12:00
Speakers
  • Mellissa Y. Williamson (South San Francisco, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

195P - Chemotherapy (CT)-induced anaemia in patients (pts) treated with dose-dense regimen: Results of the prospectively randomised anaemia substudy from the neoadjuvant GeparOcto study (ID 3928)

Presentation Number
195P
Lecture Time
12:00 - 12:00
Speakers
  • Hans Tesch (Frankfurt am Main, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

196P - The clinical impact of adjuvant dose-dense sequential chemotherapy (dds-CT) in patients with high-risk operable breast cancer (BC); pooled analysis of 6 clinical trials. (ID 2184)

Presentation Number
196P
Lecture Time
12:00 - 12:00
Speakers
  • Elena Fountzilas (Thessaloniki, Greece)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

197P - The efficacy of preoperative breast cancer chemotherapy without anti-HER2-targeted treatment – single center experience in setting of no reimbursement in Poland (2011-2015) (ID 3902)

Presentation Number
197P
Lecture Time
12:00 - 12:00
Speakers
  • Agnieszka Badora-Rybicka (Gliwice, Poland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

198P - A Multicentre, International Neoadjuvant (NA), Randomized, Double-blind Phase III Trial comparing FULVESTRANT to a combination of FULVESTRANT and PALBOCICLIB in patients with operable Luminal Breast Cancer (SAFIA Trial) (ID 4733)

Presentation Number
198P
Lecture Time
12:00 - 12:00
Speakers
  • Jean-Marc A. Nabholtz (Riyadh, Saudi Arabia)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

199P - Outcome of Non-metastatic Male Breast Cancer: 222 patients (ID 5227)

Presentation Number
199P
Lecture Time
12:00 - 12:00
Speakers
  • Ulku Yalcintas Arslan (Ankara, Turkey)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

200P - Effects of delayed initiation of adjuvant trastuzumab for non-metastatic, Her2 positive breast cancer in a limited resources setting: ML25232 study final results (ID 5943)

Presentation Number
200P
Lecture Time
12:00 - 12:00
Speakers
  • Samir Beslija (Sarajevo, Bosnia and Herzegovina)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

201P - Final results of scalp cooling for hair preservation: A single- institution prospective study. (ID 1725)

Presentation Number
201P
Lecture Time
12:00 - 12:00
Speakers
  • Dario Loparco (Brindisi, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

202P - Adjuvant Systemic Therapy in Women with Early Breast Cancer and Intermediate Prosigna ROR Scores: Is Chemotherapy Use Declining? Evidence From a Large Practice (ID 3713)

Presentation Number
202P
Lecture Time
12:00 - 12:00
Speakers
  • Lowell L. Hart (Winston Salem, FL, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

203P - Management of early breast cancer in women over 90: A 10 year experience (ID 818)

Presentation Number
203P
Lecture Time
12:00 - 12:00
Speakers
  • Emily Coffey (Manchester, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

204P - Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early- stage breast cancer. (ID 1141)

Presentation Number
204P
Lecture Time
12:00 - 12:00
Speakers
  • Daniel J. Reinhorn (Petach Tikva, Israel)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

205P - Hepatitis B screening and incidence of flare among non-metastatic breast cancer patients treated with anthracyclines (ID 2277)

Presentation Number
205P
Lecture Time
12:00 - 12:00
Speakers
  • Zewen Zhang (Singapore, Singapore)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

206P - Effect of denosumab on low bone mineral density in postmenopausal Japanese early breast cancer patients receiving aromatase nhibitors : 36-month results (ID 2781)

Presentation Number
206P
Lecture Time
12:00 - 12:00
Speakers
  • Koichi Sakaguchi (Kyoto, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

207P - Efficacy and safety of neoadjuvant chemotherapy plus trastuzumab and pertuzumab in non-metastatic HER2-positive breast cancer in real life: NEOPEARL STUDY (ID 3034)

Presentation Number
207P
Lecture Time
12:00 - 12:00
Speakers
  • Maria Agnese Fabbri (Rome, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

208P - Real world comparison of the impact of adjuvant capecitabine in women with high-risk triple-negative breast cancer after neoadjuvant chemotherapy (ID 4772)

Presentation Number
208P
Lecture Time
12:00 - 12:00
Speakers
  • Maysa T. Vilbert (Sao Paulo, Brazil)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

209P - Influence of age on the indication of adjuvant chemotherapy in early breast cancer using Oncotype DX. An analysis of 240 patients treated in the Institut Catala d’Oncologia (ICO) hospitals (ID 5627)

Presentation Number
209P
Lecture Time
12:00 - 12:00
Speakers
  • Sabela Recalde (Hospitalet de Llobregat, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

210P - Impact of delayed neoadjuvant systemic chemotherapy on survival among breast cancer patients (ID 3917)

Presentation Number
210P
Lecture Time
12:00 - 12:00
Speakers
  • Mariana Chavez Mac Gregor (Houston, TX, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

211P - Clinical Confirmation of Higher Exposure to Niraparib in Tumor vs Plasma in Patients With Breast Cancer (ID 2246)

Presentation Number
211P
Lecture Time
12:00 - 12:00
Speakers
  • Laura Spring (Boston, MA, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

212P - The rationale for the effectiveness of systemic treatment of breast cancer depending on the body weight index (ID 581)

Presentation Number
212P
Lecture Time
12:00 - 12:00
Speakers
  • Mohammad I. Hojouj (Dnipro, Ukraine)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

213P - Response to neoadjuvant chemotherapy in HER2 non-overexpressing breast cancer subtypes (ID 5327)

Presentation Number
213P
Lecture Time
12:00 - 12:00
Speakers
  • Silvia Mihaela Ilie (Bucharest, Sec. 2, Romania)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

214P - Pre-specified interim analysis of the SAFE trial (NCT2236806): a 4-arm randomized, double-blind, controlled study evaluating the efficacy and safety of cardiotoxicity prevention in non-metastatic breast cancer patients treated with anthracyclines with or without trastuzumab. (ID 3613)

Presentation Number
214P
Lecture Time
12:00 - 12:00
Speakers
  • Lorenzo Livi (Firenze, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

215P - Safety of hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-center comparative study. (ID 3736)

Presentation Number
215P
Lecture Time
12:00 - 12:00
Speakers
  • Icro Meattini (Firenze, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

216P - Usefulness of NT-ProBNP as a biomarker of cardiotoxicity in breast cancer patients treated with trastuzumab (ID 5085)

Presentation Number
216P
Lecture Time
12:00 - 12:00
Speakers
  • Isabel Blancas López-Barajas (Granada, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

217P - The routine use of sentinel lymph node biopsy in high risk DCIS lesions is not justified (ID 5747)

Presentation Number
217P
Lecture Time
12:00 - 12:00
Speakers
  • Fanny Preat (Brussels, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

218P - Oncological impact of re-excision for positive margin status after breast conserving surgery in invasive breast cancer (ID 1837)

Presentation Number
218P
Lecture Time
12:00 - 12:00
Speakers
  • Kenjiro Jimbo (Tokyo, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

219P - Pneumonitis and fibrosis after breast cancer radiation. (ID 4347)

Presentation Number
219P
Lecture Time
12:00 - 12:00
Speakers
  • Jarle Karlsen (Trondheim, Norway)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

220P - Prognosis of mastectomy with reconstruction after neoadjuvant chemotherapy: a nationwide study in Korean Breast Cancer Society (ID 2280)

Presentation Number
220P
Lecture Time
12:00 - 12:00
Speakers
  • Sungmin Park (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

221P - A negative prognosis of radiotherapy-induced lower lymphocyte to monocyte ratio in patients with breast cancer (ID 804)

Presentation Number
221P
Lecture Time
12:00 - 12:00
Speakers
  • Chang-ik Yoon (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

223P - Patient data to monitor clinical patterns in early and advanced breast cancer in Europe (ID 2701)

Presentation Number
223P
Lecture Time
12:00 - 12:00
Speakers
  • Francesco Giusti (Ispra, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

224P - A critical appraisal of quality indicators of breast cancer treatment in Belgium (ID 1437)

Presentation Number
224P
Lecture Time
12:00 - 12:00
Speakers
  • Didier M. Verhoeven (Brasschaat, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

225P - Predictors of adherence among post-menopausal women receiving adjuvant endocrine therapy for breast cancer in Ontario, Canada (ID 1534)

Presentation Number
225P
Lecture Time
12:00 - 12:00
Speakers
  • Phillip Blanchette (London, Canada)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

226P - Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study (ID 4363)

Presentation Number
226P
Lecture Time
12:00 - 12:00
Speakers
  • Emilia Montagna (Milan, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

227P - Baseline Quality of life (QoL) and chemotherapy related toxicities (CRT) in localized breast cancer (BC) patients (pts): the French multicentric prospective CANTO cohort study (ID 2679)

Presentation Number
227P
Lecture Time
12:00 - 12:00
Speakers
  • Idlir Licaj (Caen, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

228P - Effects of Aerobic and Resistance Exercise on Android:Gynoid Fat Ratio in Breast Cancer Survivors (ID 2840)

Presentation Number
228P
Lecture Time
12:00 - 12:00
Speakers
  • Christina Dieli-Conwright (Los Angeles, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

229P - Impact of Education for Breast self examination in Rural Indian Women on Early Detection - results of POC study (ID 869)

Presentation Number
229P
Lecture Time
12:00 - 12:00
Speakers
  • Sneha S. Parchuri (Hyderabad, India)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

230P - Breast cancer incidence and survival in renal transplant patients: 35-year experience (ID 1951)

Presentation Number
230P
Lecture Time
12:00 - 12:00
Speakers
  • Michalis Kontos (Athens, Greece)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

231P - The changing landscape of breast cancer incidence after treatment for Hodgkin’s disease (ID 2017)

Presentation Number
231P
Lecture Time
12:00 - 12:00
Speakers
  • Amelia J. Benjamin (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

233P - Number of deliveries as a prognostic factor in different breast cancer subtypes (ID 1780)

Presentation Number
233P
Lecture Time
12:00 - 12:00
Speakers
  • Anniina Jääskeläinen (Oulu University Hospital, Finland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

234P - Effects of supervised and adapted exercise program in the quality of life and strength of breast cancer survivors: MAMA MOVE Gaia trial (ID 4650)

Presentation Number
234P
Lecture Time
12:00 - 12:00
Speakers
  • Ana Joaquim (Vila Nova de Gaia, Porto, Portugal)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

235P - Study On the Socioeconomic and Clinical Factors Affecting the Proportion of Breast Conserving Surgery in Chinese Women Breast Cancer (ID 4962)

Presentation Number
235P
Lecture Time
12:00 - 12:00
Speakers
  • Jin Zhang (Tianjin, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

236P - Clinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program? (ID 5451)

Presentation Number
236P
Lecture Time
12:00 - 12:00
Speakers
  • Marco Giavarra (Udine, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

237P - The value of genetic counselling in breast cancer genetic testing and clinical management (ID 888)

Presentation Number
237P
Lecture Time
12:00 - 12:00
Speakers
  • Vicki Kiesel (Cambridge, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

238P - Elderly patients in the Japanese Breast Cancer Registry (ID 4005)

Presentation Number
238P
Lecture Time
12:00 - 12:00
Speakers
  • Masataka Sawaki (Nagoya, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

239P - Tumour-infiltrating lymphocytes and BRCA-like status in stage III breast cancer patients treated with intensified carboplatin-based chemotherapy (ID 3330)

Presentation Number
239P
Lecture Time
12:00 - 12:00
Speakers
  • Leonora De Boo (Amsterdam, Netherlands)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

240P - Unravelling the biological characteristics of MammaPrint extreme risk subgroups (ID 3971)

Presentation Number
240P
Lecture Time
12:00 - 12:00
Speakers
  • Rajith Bhaskaran (Amsterdam, Netherlands)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

241P - Residual Cancer burden as a prognostic factor in a large series of Neoadjuvant chemotherapy. Subgroup analysis per molecular surrogated subtypes (ID 5871)

Presentation Number
241P
Lecture Time
12:00 - 12:00
Speakers
  • Catalina Falo (Hospitalet de Llobregat, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

242P - Clinical validation of CanAssist Breast in a Spanish cohort (ID 5014)

Presentation Number
242P
Lecture Time
12:00 - 12:00
Speakers
  • Manjiri Bakre (Bangalore, Karnatala, India)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

243P - Meta-analysis on association of pathological complete response with long-term survival outcomes in triple-negative breast cancer (ID 2787)

Presentation Number
243P
Lecture Time
12:00 - 12:00
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

244P - Immune infiltrate composition across intrinsic subtypes in hormone receptor (HR)+/HER2- early breast cancer (BC) enrolled in the prospective LETLOB trial (ID 4301)

Presentation Number
244P
Lecture Time
12:00 - 12:00
Speakers
  • Gaia Griguolo (Padova, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

245P - Frequency of germline mutations in women's cancer susceptibility genes in a large cohort of Chinese breast cancer patients (ID 3205)

Presentation Number
245P
Lecture Time
12:00 - 12:00
Speakers
  • Ning Liao (Guangzhou, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

246P - Triple blinded Prospective Study assessing the Impact of Genomics & Artificial Intelligence Watson For Oncology (WFO) on MDT’s Decision of Adjuvant Systemic Therapy for Hormone Receptor Positive Early Breast Carcinoma- (ID 4091)

Presentation Number
246P
Lecture Time
12:00 - 12:00
Speakers
  • Somashekhar Sampige Prasannakumar (Bangalore, Karnataka, India)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

247P - Prognostic significance of Progesterone Receptor levels in luminal-like Her2- early Breast Cancer patients. A retrospective single Cancer Center analysis. (ID 4359)

Presentation Number
247P
Lecture Time
12:00 - 12:00
Speakers
  • Anna Diana (Napoli, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

248P - PAM50 HER2-enriched subtype and pathological complete response in HER2-positive early breast cancer: a meta-analysis (ID 1369)

Presentation Number
248P
Lecture Time
12:00 - 12:00
Speakers
  • Francesco Schettini (Napoli, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

249P - Assessment of CPS+EG, Neo-Bioscore and modified Neo-Bioscore in breast cancer patients treated with preoperative systemic therapy: a multicenter cohort study (ID 1058)

Presentation Number
249P
Lecture Time
12:00 - 12:00
Speakers
  • LING XU (Beijing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

250P - The concordance of treatment decision guided by Oncotype and the PREDICT tool in early stage breast cancer (ID 1156)

Presentation Number
250P
Lecture Time
12:00 - 12:00
Speakers
  • Hadar Goldvaser (Toronto, Canada)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

251P - Influence of first treatment delay on survival among breast cancer subtypes (ID 3447)

Presentation Number
251P
Lecture Time
12:00 - 12:00
Speakers
  • Irene Zarcos Pedrinaci (Marbella, Málaga, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

252P - Clinical features of early-stage (I-III) triple-negative breast cancer (TNBC) patients with tumors exhibiting low-overall change in molecular profile after neoadjuvant therapy. (ID 3505)

Presentation Number
252P
Lecture Time
12:00 - 12:00
Speakers
  • Nour Abuhadra (Houston, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

253P - Meta-analysis in HER2+ early breast cancer therapies and cost-effectiveness in a Brazilian perspective (ID 5442)

Presentation Number
253P
Lecture Time
12:00 - 12:00
Speakers
  • Marcos Magalhaes (Santo Andre, Brazil)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

254P - Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer(BC); a prospective clinical study (ID 1570)

Presentation Number
254P
Lecture Time
12:00 - 12:00
Speakers
  • Cetin Ordu (Istanbul, Balıkesir Province, Turkey)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

255P - Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy. (ID 2698)

Presentation Number
255P
Lecture Time
12:00 - 12:00
Speakers
  • Giuseppe Cancello (Milan, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

256P - Novel Blood Based Circulating Tumor Cell Biomarker For Breast Cancer Detection (ID 3104)

Presentation Number
256P
Lecture Time
12:00 - 12:00
Speakers
  • Chun-Yu Liu (Taipei, Taiwan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

257P - Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response of ER-Positive HER2-Negative Breast Cancer Patients to Neo-Adjuvant Chemotherapy (ID 4631)

Presentation Number
257P
Lecture Time
12:00 - 12:00
Speakers
  • Claudia Mazo (Dublin, Ireland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

258P - Impact of menopause status on breast cancer outcomes and amenorrhea incidence during adjuvant tailored dose dense chemotherapy (ID 4632)

Presentation Number
258P
Lecture Time
12:00 - 12:00
Speakers
  • Andri Papakonstantinou (Stockholm, Sweden)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

259P - Progesterone Receptor Isoform Ratio Dictates Antiprogestins/Progestins Effects on Metastatic Breast Cancer Models (ID 4732)

Presentation Number
259P
Lecture Time
12:00 - 12:00
Speakers
  • Maria F. Abascal (Buenos Aires, Argentina)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

260P - PAM50 and CGH-array genomic characterization of HER2-Equivocal Breast Cancers defined by the 2018 ASCO/CAP recommendations. (ID 5737)

Presentation Number
260P
Lecture Time
12:00 - 12:00
Speakers
  • Carine Ngo (Paris, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

261P - OncotypeDX® predictive nomogram for recurrence score output: a machine learning system based on quantitative immunochemistry analysis - ADAPTED01 (ID 1096)

Presentation Number
261P
Lecture Time
12:00 - 12:00
Speakers
  • Fabio Marazzi (Roma, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

262P - Geriatric parameters predict both disease-related and patient-reported outcomes in older patients with breast cancer (ID 5426)

Presentation Number
262P
Lecture Time
12:00 - 12:00
Speakers
  • Willeke Van der Plas-Krijgsman (Leiden, Netherlands)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

263P - Patients with a 21-gene assay in South East London differ from the TAILORx trial population (ID 5865)

Presentation Number
263P
Lecture Time
12:00 - 12:00
Speakers
  • Charalampos Gousis (Kavala, Greece)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

264P - Predictive tools in adjuvant breast cancer – what is the standard of evidence supporting their utility? A literature review examining validation of Adjuvant!, Cancermath and NHS Predict (ID 1312)

Presentation Number
264P
Lecture Time
12:00 - 12:00
Speakers
  • Alice R. Loft (Christchurch, New Zealand)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

265P - Oncologic outcome of invasive lobular carcinoma: Is it different from that of invasive ductal carcinoma? (ID 2445)

Presentation Number
265P
Lecture Time
12:00 - 12:00
Speakers
  • Hee Jun Choi (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

266P - Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer (ID 2476)

Presentation Number
266P
Lecture Time
12:00 - 12:00
Speakers
  • SERAFIN MORALES Murillo (Lleida, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

267P - Chemotherapy-induced amenorrhea: prognostic impact on premenopausal Egyptian patients with breast cancer (ID 3761)

Presentation Number
267P
Lecture Time
12:00 - 12:00
Speakers
  • Khaled Abdel Karim (Cairo, Egypt)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

269P - Predicting the presence of breast cancer using circulating small RNA in the serum (ID 4687)

Presentation Number
269P
Lecture Time
12:00 - 12:00
Speakers
  • Yumiko Koi (Hatsukaichi, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

270P - Evaluation of germ line mutational status among women with triple-negative breast cancer in Russia (ID 5612)

Presentation Number
270P
Lecture Time
12:00 - 12:00
Speakers
  • Elena Shagimardanova (Kazan, Russian Federation)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

271P - Association of derived neutrophil-to-lymphocyte ratio (dNLR) with pathological complete response (pCR) after neoadjuvant chemotherapy (CT) (ID 4142)

Presentation Number
271P
Lecture Time
12:00 - 12:00
Speakers
  • Alberto Ocaña (San Sebastian de los Reyes, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

272P - Competing nomogram for late-period breast cancer-specific death in patients with early-stage hormone receptor-positive breast cancer (ID 1733)

Presentation Number
272P
Lecture Time
12:00 - 12:00
Speakers
  • Jianfei Fu (JInhua, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

273P - A Nomogram to Predict Pathologic Complete Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Based on Simple Blood Indicators (ID 1978)

Presentation Number
273P
Lecture Time
12:00 - 12:00
Speakers
  • Fanrong Zhang (Hangzhou, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

274P - Identification of GSTP1 transferred by extracellular vesicles responsible for adriamycin-resistance in breast cancer cells (ID 3062)

Presentation Number
274P
Lecture Time
12:00 - 12:00
Speakers
  • Sujin Yang (Jiangsu, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

275P - Expression of X-linked Inhibitor of Apoptosis Protein (XIAP) and its Association with Clinicopathological Parameters in Invasive Breast Cancers (ID 5274)

Presentation Number
275P
Lecture Time
12:00 - 12:00
Speakers
  • Gayathri Devi (Durham, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

276P - The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients (ID 1324)

Presentation Number
276P
Lecture Time
12:00 - 12:00
Speakers
  • Soo Youn Bae (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

277P - Correlation of clinical and pathological features with the tumour microenvironment in DCIS. An institutional experience (ID 4877)

Presentation Number
277P
Lecture Time
12:00 - 12:00
Speakers
  • Ann Eapen (Orange, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

278P - Correlation between radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer and pathologic complete response and their impact in recurrence-free survival (ID 2471)

Presentation Number
278P
Lecture Time
12:00 - 12:00
Speakers
  • Ariadna Gasol Cudos (Lleida, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

279P - Ring-like uptake appearance on dedicated breast positron emission tomography before chemotherapy predicts outcome of neoadjuvant chemotherapy in breast cancer (ID 2632)

Presentation Number
279P
Lecture Time
12:00 - 12:00
Speakers
  • Norio Masumoto (Hiroshima, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

280P - Defining a SUV decrease cut-off in PET/CT response monitoring after one cycle of preoperative breast cancer chemotherapy (ID 3911)

Presentation Number
280P
Lecture Time
12:00 - 12:00
Speakers
  • Marcin Kubeczko (Gliwice, Poland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

281P - Effect of thioredoxin 1 quantity detection to complement the mammography in breast cancer diagnosis (ID 1849)

Presentation Number
281P
Lecture Time
12:00 - 12:00
Speakers
  • Younju Lee (Daejeon, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

282P - Identification of ultralow risk breast cancer patients (probable overdiagnosis) (ID 2221)

Presentation Number
282P
Lecture Time
12:00 - 12:00
Speakers
  • Salvador Gamez Casado (Cadiz, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

283P - Prevalence of Vitamin D3 deficiency among women with early breast cancer receiving chemotherapy in an oncology dayward. (ID 5291)

Presentation Number
283P
Lecture Time
12:00 - 12:00
Speakers
  • Warner Finstad (Cork, Ireland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

284P - Changes in ER pathway activity score during neoadjuvant letrozole to assess therapy response and predict disease free survival (DFS) in ER positive breast cancer patients (ID 4247)

Presentation Number
284P
Lecture Time
12:00 - 12:00
Speakers
  • Arran K. Turnbull (Edinburgh, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

285P - Second primary malignancies in patients with breast cancer. (ID 568)

Presentation Number
285P
Lecture Time
12:00 - 12:00
Speakers
  • Carlos Erasun Lecuona (Barcelona, Barcelona, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

286TiP - Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen receptor & HER2 positive (ER+/HER2+) Breast Cancer (BC) (International Breast Cancer Study Group IBCSG 55-17, TOUCH) (ID 1428)

Presentation Number
286TiP
Lecture Time
12:00 - 12:00
Speakers
  • Laura Biganzoli (Prato, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

287TiP - Neoadjuvant HER2-targeted therapy with or without immunotherapy with pembrolizumab (neoHIP): an open label randomized phase 2 trial (ID 1479)

Presentation Number
287TiP
Lecture Time
12:00 - 12:00
Speakers
  • Heather L. McArthur (Los Angeles, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

288TiP - A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy (ID 1481)

Presentation Number
288TiP
Lecture Time
12:00 - 12:00
Speakers
  • Heather L. McArthur (Los Angeles, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

289TiP - ALEXANDRA/IMpassion030: A phase 3 study of standard adjuvant chemotherapy with or without atezolizumab in early stage triple negative breast cancer. (ID 4334)

Presentation Number
289TiP
Lecture Time
12:00 - 12:00
Speakers
  • Michail Ignatiadis (Brussels, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

290TiP - Role of Individualized Intervention(s) on Quality of Life (QOL) and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women with Early-Stage Breast Cancer (BC): MyChoice Study (ID 2107)

Presentation Number
290TiP
Lecture Time
12:00 - 12:00
Speakers
  • Shahid Ahmed (Saskatoon, Canada)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

291TiP - Correlation between the density of tumor-infiltrating lymphocytes, immune cell subsets in tumor stroma and response to systemic therapy in breast cancer (ID 5812)

Presentation Number
291TiP
Lecture Time
12:00 - 12:00
Speakers
  • Cvetka Grasic Kuhar (Ljubljana, Slovenia)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

Breast cancer, locally advanced (ID 6627)

Lecture Time
12:00 - 12:00
Speakers
  • Sung-Bae Kim (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

292P - BRCA1/2 Testing in HER2- Advanced Breast Cancer (ABC): Results from the European Component of a Multi-Country Real World Study (ID 4734)

Presentation Number
292P
Lecture Time
12:00 - 12:00
Speakers
  • Michael Patrick Lux (Paderborn, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

293P - In vitro and in vivo rescue of resistance to BET inhibitors by targeting PLK1 in triple negative breast cancer. (ID 1686)

Presentation Number
293P
Lecture Time
12:00 - 12:00
Speakers
  • Cristina Nieto-jiménez (Albacete, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

294P - Neoadjuvant endocrine therapy in combination with melatonin and metformin in locally advanced breast cancer (ID 5020)

Presentation Number
294P
Lecture Time
12:00 - 12:00
Speakers
  • Tatiana Y. Semiglazova (Saint-Petersburg, Russian Federation)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

295P - Melatonin and metformin in neoadjuvant chemotherapy in locally advanced breast cancer (ID 5082)

Presentation Number
295P
Lecture Time
12:00 - 12:00
Speakers
  • Tatiana Y. Semiglazova (Saint-Petersburg, Russian Federation)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

296P - Patient-tailored tamoxifen dosing based on an increased quantitative understanding of its complex pharmacokinetics: A novel integrative modelling approach (ID 2642)

Presentation Number
296P
Lecture Time
12:00 - 12:00
Speakers
  • Anna Mueller-Schoell (Berlin, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

297P - Lack of benefit of neoadjuvant pertuzumab in high risk HER2 positive breast cancer. A retrospective case-control study of 355 cases with biomarker analysis. (ID 2461)

Presentation Number
297P
Lecture Time
12:00 - 12:00
Speakers
  • Manuela Tiako Meyo (Paris, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

298P - Targeting CDCA3 to improve chemotherapy response in triple-negative breast cancer patients (ID 4776)

Presentation Number
298P
Lecture Time
12:00 - 12:00
Speakers
  • Kenneth J. O'Byrne (Woolloongabba, QLD, Australia)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

299P - Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer (ID 1674)

Presentation Number
299P
Lecture Time
12:00 - 12:00
Speakers
  • María Del Mar Noblejas López (Albacete, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

300P - Outcome of triple negative inflammatory breast cancers (TNIBC) treated with dose dense neoadjuvant epirubicin cyclophosphmide, prognostic impact of pre and post neoadjuvant chemotherapy (NAC) tumor infiltrating lymphocytes (TIL) and post NAC lymphovascular invasion (ID 5629)

Presentation Number
300P
Lecture Time
12:00 - 12:00
Speakers
  • Luca Campedel (Paris, CEDEX 13, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

301P - A novel PET parameter for cancer stem cell metabolism: early prediction of chemosensitivity to neoadjuvant chemotherapy in locally advanced breast cancer (ID 5792)

Presentation Number
301P
Lecture Time
12:00 - 12:00
Speakers
  • Chanwoo Kim (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

302P - Using nodal ratio to predict recurrence in patients with 4 or more positive lymph nodes early stage breast cancer (ID 3728)

Presentation Number
302P
Lecture Time
12:00 - 12:00
Speakers
  • Besma Graja (Tunis, Tunisia)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

303P - Re-sentinel node biopsy for local recurrence after breast-conserving surgery (ID 3395)

Presentation Number
303P
Lecture Time
12:00 - 12:00
Speakers
  • Yuka Matsubara (Yokohama, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

304P - Assessment of prognostic and therapeutic factors in men with breast cancer (ID 4302)

Presentation Number
304P
Lecture Time
12:00 - 12:00
Speakers
  • Daniel Herrero Rivera (Sevilla, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

Breast cancer, metastatic (ID 6628)

Lecture Time
12:00 - 12:00
Speakers
  • Sung-Bae Kim (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

312P - Genomic Profiling of Chinese Breast Cancer Patients (ID 4263)

Presentation Number
312P
Lecture Time
12:00 - 12:00
Speakers
  • Zhonghua Tao (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

313P - Genome copy number alteration burden represents predictor of response in long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer (ID 2406)

Presentation Number
313P
Lecture Time
12:00 - 12:00
Speakers
  • Naomi Walsh (Dublin, Ireland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

314P - Next-generation DNA Sequencing (NGS) Results for Tumors From Phase 2 ABRAZO Study of Talazoparib After Platinum or Cytotoxic Non-Platinum Regimens in Patients (pts) With Advanced Breast Cancer (ABC) and Germline BRCA1/2 (gBRCA) Mutations (ID 2575)

Presentation Number
314P
Lecture Time
12:00 - 12:00
Speakers
  • Nicholas C. Turner (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

315P - FGFR1 and CCND1 gene amplifications are associated with breast cancer resistance to aromatase inhibitors (ID 4499)

Presentation Number
315P
Lecture Time
12:00 - 12:00
Speakers
  • Evgeny Imyanitov (Saint-Petersburg, Russian Federation)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

316P - Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe Experience (ID 4110)

Presentation Number
316P
Lecture Time
12:00 - 12:00
Speakers
  • Sercan Aksoy (Ankara, Turkey)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

317P - Novel fusion genes identified from matched primary and recurred breast cancers by RNA-sequencing (ID 5203)

Presentation Number
317P
Lecture Time
12:00 - 12:00
Speakers
  • Soojeong Choi (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

318P - Association between PIK3CA mutation status and development of brain metastases in HR+/HER2- metastatic breast cancer (ID 5873)

Presentation Number
318P
Lecture Time
12:00 - 12:00
Speakers
  • Donna M. Fitzgerald (Boston, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

319P - The role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: a translational approach. (ID 3588)

Presentation Number
319P
Lecture Time
12:00 - 12:00
Speakers
  • Anna Adam-Artigues (Valencia, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

320P - Untargeted assessment of tumor fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment (ID 5640)

Presentation Number
320P
Lecture Time
12:00 - 12:00
Speakers
  • Marija Balic (Graz, Austria)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

321P - Clinical application of mutational analysis in breast cancer patients: the relevance of PIK3CA analysis for precision medicine. (ID 2616)

Presentation Number
321P
Lecture Time
12:00 - 12:00
Speakers
  • Juan Miguel Cejalvo (Valencia, Valencia, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

322P - A retrospective gene expression analysis of surgically-removed Breast Cancer Brain Metastasis (BCBM) (ID 3870)

Presentation Number
322P
Lecture Time
12:00 - 12:00
Speakers
  • Meritxell Mallafré-Larrosa (Barcelona, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

323P - Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: meta-analysis of Phase II and III randomized clinical trials (ID 1240)

Presentation Number
323P
Lecture Time
12:00 - 12:00
Speakers
  • Claudia Omarini (Modena, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

324P - Alpelisib (ALP) + fulvestrant (FUL) for patients with hormone receptor–positive (HR+), HER2− advanced breast cancer (ABC): management and time course of key adverse events of special interest (AESIs) in SOLAR-1 (ID 5535)

Presentation Number
324P
Lecture Time
12:00 - 12:00
Speakers
  • Hope S. Rugo (San Francisco, CA, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

325P - Changes in Hormone-Receptor status in Luminal breast cancers between primary tumor and metastases: results of the observational cohort GIM-13 AMBRA Study (ID 3093)

Presentation Number
325P
Lecture Time
12:00 - 12:00
Speakers
  • Marina E. Cazzaniga (Monza, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

326P - MONARCH 3: Updated time to chemotherapy and disease progression following abemaciclib plus aromatase inhibitor (AI) in HR+, HER2- advanced breast cancer (ABC) (ID 1378)

Presentation Number
326P
Lecture Time
12:00 - 12:00
Speakers
  • Miguel Martín (Madrid, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

327P - Palbociclib plus an aromatase inhibitor as first-line therapy for metastatic breast cancer in US clinical practices: Real-world progression-free survival analysis (ID 3536)

Presentation Number
327P
Lecture Time
12:00 - 12:00
Speakers
  • Mylin Torres (Atlanta, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

328P - Ribociclib (RIB) plus letrozole (LET) in male patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) from the CompLEEment-1 trial (ID 4022)

Presentation Number
328P
Lecture Time
12:00 - 12:00
Speakers
  • Mario Campone (Nantes, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

329P - Comparative effectiveness of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US real-world clinical practices (ID 3599)

Presentation Number
329P
Lecture Time
12:00 - 12:00
Speakers
  • Rachel M. Layman (Houston, TX, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

330P - Pharmacokinetics (PK), safety, and efficacy of [fam-] trastuzumab deruxtecan with OATP1B/CYP3A inhibitors in subjects with HER2-expressing advanced solid tumors (ID 901)

Presentation Number
330P
Lecture Time
12:00 - 12:00
Speakers
  • Yung-Jue Bang (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

331P - A Phase 2 study of abemaciclib in patients (pts) with brain metastases (BM) secondary to non-small cell lung cancer (NSCLC) or melanoma (MEL). (ID 2777)

Presentation Number
331P
Lecture Time
12:00 - 12:00
Speakers
  • Solmaz Sahebjam (Tampa, FL, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

332P - Ribociclib (RIB) + letrozole (LET) in patients (pts) with visceral metastases (VM) or bone-only metastases (BOM) in hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC): Subgroup analysis from the CompLEEment-1 trial (ID 3980)

Presentation Number
332P
Lecture Time
12:00 - 12:00
Speakers
  • Michelino De Laurentiis (Naples, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

333P - Ribociclib (RIB) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) and central nervous system (CNS) metastases: Subgroup analysis from the phase 3b CompLEEment-1 trial (ID 4024)

Presentation Number
333P
Lecture Time
12:00 - 12:00
Speakers
  • Paul H. Cottu (Paris, CEDEX 5, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

334P - Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting. (ID 2151)

Presentation Number
334P
Lecture Time
12:00 - 12:00
Speakers
  • Elena Fountzilas (Thessaloniki, Greece)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

335P - Safety and efficacy of Ribociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): Interim results from the Italian cohort of the CompLEEment-1 (C-1) study. (ID 3994)

Presentation Number
335P
Lecture Time
12:00 - 12:00
Speakers
  • Michele De Laurentiis (Napoli, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

336P - Interim Results From CompLEEment-1 (A Phase 3b Study of Ribociclib and Letrozole as First-Line Therapy for Advanced Breast Cancer in an Expanded Population): Spanish cohort results (ID 1370)

Presentation Number
336P
Lecture Time
12:00 - 12:00
Speakers
  • Javier Salvador (Sevilla, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

337P - First Canadian Interim Analysis from the Phase IIIb CompLEEment-1 Ribociclib + Letrozole HR+ HER2- Advanced Breast Cancer Trial (ID 1109)

Presentation Number
337P
Lecture Time
12:00 - 12:00
Speakers
  • Cristiano Ferrario (Montreal, QC, Canada)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

338P - Real-world effectiveness of first-line palbociclib + letrozole for metastatic breast cancer 4 years post approval in the US (ID 4401)

Presentation Number
338P
Lecture Time
12:00 - 12:00
Speakers
  • Jonathan Kish (Dublin, OH, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

339P - Palbociclib-Fulvestrant (PALBO-FUL) and Everolimus -Exemestane (EVE-EXE) for Second line Hormonal Treatment (HT) of Metastatic Breast Cancer (MBC) with Lobular Histology: a Propensity Score Matched Analysis of a Multicenter ‘Real-World’ Patients (pts) Series. (ID 5876)

Presentation Number
339P
Lecture Time
12:00 - 12:00
Speakers
  • Armando Orlandi (Rome, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

340P - Dose-escalation study of G1T48, an oral selective estrogen receptor degrader (SERD), in postmenopausal women with ER+/HER2- locally advanced or metastatic breast cancer (ABC) (ID 3587)

Presentation Number
340P
Lecture Time
12:00 - 12:00
Speakers
  • E C. Dees (Chapel Hill, AL, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

341P - Final results of the STEM trial: SFX-01 in the Treatment and Evaluation of ER+ Her2- Metastatic breast cancer (mBC) (ID 5696)

Presentation Number
341P
Lecture Time
12:00 - 12:00
Speakers
  • Sacha J. Howell (Manchester, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

342P - Alpelisib (ALP) + Fulvestrant (FUL) in Hormone-Receptor Positive (HR+), Human Epidermal Growth Factor Receptor-2–Negative (HER2–) Advanced Breast Cancer (ABC): Subgroup Analysis by Presence of Visceral Metastasis (VM) in the SOLAR-1 Trial (ID 1475)

Presentation Number
342P
Lecture Time
12:00 - 12:00
Speakers
  • Mario Campone (Saint-Herblain, CEDEX, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

343P - Phase 1 Dose Escalation Study of a Selective Androgen Receptor Modulator RAD140 in Estrogen Receptor Positive (ER+), HER2 Negative (HER2-) Breast Cancer (BC) (ID 2549)

Presentation Number
343P
Lecture Time
12:00 - 12:00
Speakers
  • Erika Hamilton (Nashville, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

344P - A Phase I study of XZP-3287, a novel oral CDK4/6 Inhibitor, administered on a continuous dosing schedule, in patients with advanced solid tumours (ID 3787)

Presentation Number
344P
Lecture Time
12:00 - 12:00
Speakers
  • Binghe Xu (Beijing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

345P - Phase-I dose-escalation and expansion study of the PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors (ID 4835)

Presentation Number
345P
Lecture Time
12:00 - 12:00
Speakers
  • Huiping Li (Beijing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

346P - Phase 2 study of DHP107 (Liporaxel®, oral paclitaxel) in first-line, HER2 negative recurrent/metastatic breast cancer (OPTIMAL study, NCT03315364) (ID 5083)

Presentation Number
346P
Lecture Time
12:00 - 12:00
Speakers
  • Jin-Hee Ahn (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

347P - Multicenter Phase I Trial of Trastuzumab Emtansine (T-DM1) in Combination with Non-Pegylated Liposomal Doxorubicin (NPLD) in HER2[+] Metastatic Breast Cancer (MBC). THELMA Study (ID 2674)

Presentation Number
347P
Lecture Time
12:00 - 12:00
Speakers
  • Elena López-Miranda (Madrid, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

348P - Phase 1 study of liposomal formulation of eribulin (E7389-LF) in patients (pts) with advanced solid tumors: primary results of dose-escalation part (ID 1398)

Presentation Number
348P
Lecture Time
12:00 - 12:00
Speakers
  • Noboru Yamamoto (Tokyo, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

349P - Polo-like Kinase 1 inhibitor onvansertib synergizes with paclitaxel in breast cancer carrying p53 mutation (ID 5818)

Presentation Number
349P
Lecture Time
12:00 - 12:00
Speakers
  • Antonio Giordano (Charleston, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

350P - Phase 1b study of heat shock protein 90 inhibitor, onalespib in combination with paclitaxel in patients with advanced, triple negative breast cancer (NCT02474173). (ID 5927)

Presentation Number
350P
Lecture Time
12:00 - 12:00
Speakers
  • Robert Wesolowski (Columbus, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

351P - Impact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: results from the AGMT_MBC-Registry (ID 1695)

Presentation Number
351P
Lecture Time
12:00 - 12:00
Speakers
  • Simon Peter P. Gampenrieder (Salzburg, Austria)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

352P - Clinical profile and outcome of HER2 positive breast cancer patients with brain metastases treated with HER2 targeted therapy: Real world experience. (ID 1742)

Presentation Number
352P
Lecture Time
12:00 - 12:00
Speakers
  • Prabhat G. Bhargava (Mumbai, India)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: results of single arm phase IV COMACHI study (ID 1846)

Presentation Number
353P
Lecture Time
12:00 - 12:00
Speakers
  • Norikazu Masuda (Osaka, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

354P - Anti HER-2 Therapies and Left Ventricular Dysfunction The Renaissance Study (ID 5385)

Presentation Number
354P
Lecture Time
12:00 - 12:00
Speakers
  • ANDRES J. DANIELE (Caba, Argentina)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

355P - Safety and efficacy of T-DM1 in 128 patients with advanced HER2+ breast cancer: The Royal Marsden experience. (ID 3320)

Presentation Number
355P
Lecture Time
12:00 - 12:00
Speakers
  • Nicolò M. Battisti (Sutton, Surrey, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

356P - Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): challenges in assessing effectiveness of treatment sequencing in the real world (RW) (ID 4540)

Presentation Number
356P
Lecture Time
12:00 - 12:00
Speakers
  • Thibaut Sanglier (Basel, Switzerland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

357P - Patient Reported Outcomes (PRO) in patients (pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician’s choice chemotherapy (PCT) in the EMBRACA trial: A focus on subgroups with/ without visceral disease (ID 2376)

Presentation Number
357P
Lecture Time
12:00 - 12:00
Speakers
  • Johannes Ettl (München, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

358P - Complete Responses in Patients With 2nd-Line or Greater Metastatic Triple-Negative Breast Cancer (TNBC) Following First-in-Human Immunotherapy Combining NK and T Cell Activation with Off-the-Shelf High-Affinity CD16 NK Cell Line (haNK) (ID 4874)

Presentation Number
358P
Lecture Time
12:00 - 12:00
Speakers
  • Chaitali Nangia (Costa Mesa, CA, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

359P - Reproducibility and concordance of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays in triple-negative breast cancer (TNBC) (ID 4362)

Presentation Number
359P
Lecture Time
12:00 - 12:00
Speakers
  • Aurelia Noske (Munich, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

360P - Systemic Therapy in 2nd-Line Metastatic Triple Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR) and Meta-Analysis (MA) of Efficacy (ID 4528)

Presentation Number
360P
Lecture Time
12:00 - 12:00
Speakers
  • Peter A. Kaufman (Lebanon, NH, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

361P - Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia (ID 4112)

Presentation Number
361P
Lecture Time
12:00 - 12:00
Speakers
  • Yang Chen (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

362P - Patterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC) (ID 5699)

Presentation Number
362P
Lecture Time
12:00 - 12:00
Speakers
  • Joyce O’Shaughnessy (Dallas, TX, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

363P - Maintenance Chemotherapy is effective in Patients with Metastatic Triple Negative Breast Cancer After First-line Platinum-based Chemotherapy (ID 1931)

Presentation Number
363P
Lecture Time
12:00 - 12:00
Speakers
  • Jian Zhang (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

364P - Using the Patient-Reported Outcomes Measurement Information System (PROMIS) to investigate symptom burden enrichment in Stage IV patients at an academic center (ID 4696)

Presentation Number
364P
Lecture Time
12:00 - 12:00
Speakers
  • Madeline Matthys (San Francisco, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

365P - Measures of functional status in adults aged ≥70 years with advanced breast cancer (ABC) receiving palbociclib (PAL) combination therapy in POLARIS (ID 4582)

Presentation Number
365P
Lecture Time
12:00 - 12:00
Speakers
  • Meghan S. Karuturi (Houston, TX, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

366P - Real-World 1-Year Survival Analysis of Patients with Metastatic Breast Cancer with Liver or Lung Metastasis Treated with Eribulin, Gemcitabine or Capecitabine (ID 3565)

Presentation Number
366P
Lecture Time
12:00 - 12:00
Speakers
  • Shayma M. Kazmi (Philadelphia, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

367P - Prognostic impact of Body Mass Index (BMI) on overall survival in patients with metastatic breast cancer (ID 3608)

Presentation Number
367P
Lecture Time
12:00 - 12:00
Speakers
  • Khalil SALEH (Villejuif, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

368P - Clinicopathological characteristics, survival and prognostic factors of breast cancer-related microangiopathic haemolytic anemia: a multicenter study (ID 2686)

Presentation Number
368P
Lecture Time
12:00 - 12:00
Speakers
  • Marion Alhenc Gelas (Paris, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

369P - Metabolic tumor volume by 18F-FDG PET/CT is an independent prognostic factor in metastatic breast cancer (ID 1565)

Presentation Number
369P
Lecture Time
12:00 - 12:00
Speakers
  • Heekyung Ahn (Incheon, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

370P - Patient Preferences for breast cancer treatments: A Discrete Choice Experiment from four European countries (ID 4498)

Presentation Number
370P
Lecture Time
12:00 - 12:00
Speakers
  • Thomais Konstantopoulou (Origgio, Not Applicable, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

371P - Palbociclib plus fulvestrant as second- or later-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase 2 study (ID 1423)

Presentation Number
371P
Lecture Time
12:00 - 12:00
Speakers
  • Diana Lüftner (Berlin, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

372P - Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype (ID 2284)

Presentation Number
372P
Lecture Time
12:00 - 12:00
Speakers
  • Hee Kyung Kim (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

373P - Administration of chemotherapy for metastatic breast cancer near the end of life: a population registry study (ID 4598)

Presentation Number
373P
Lecture Time
12:00 - 12:00
Speakers
  • Luisa Edman Kessler (Stockholm, Sweden)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

374P - Prognostic value of histological growth pattern in patients operated for breast cancer liver metastases (ID 5706)

Presentation Number
374P
Lecture Time
12:00 - 12:00
Speakers
  • Ali Bohlok (Brussels, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

375P - Illness perceptions, quality of life and mood in metastatic breast cancer patients (ID 1697)

Presentation Number
375P
Lecture Time
12:00 - 12:00
Speakers
  • Isabel Domingues (Coimbra, Portugal)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

376P - Multidisciplinary Treatments Increases Overall Survival in Patients with Newly Diagnosed Stage IV Breast Cancer:An Analysis of 2010–2014 SEER Data (ID 1935)

Presentation Number
376P
Lecture Time
12:00 - 12:00
Speakers
  • Jian Zhang (Jinan, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

377P - Correlation of radiotherapy with the prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping (ID 3875)

Presentation Number
377P
Lecture Time
12:00 - 12:00
Speakers
  • Jin Zhang (Tianjin, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

378P - Real world treatment sequencing patterns in secondary breast cancer (SBC): Pathway visualisation using national datasets. (ID 5793)

Presentation Number
378P
Lecture Time
12:00 - 12:00
Speakers
  • Ashley W. Horne (Edinburgh, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

379P - Utilization Pattern of Bone Targeting Agents in Patients with Solid Tumor in Taiwan, Hong Kong and Korea (ID 3185)

Presentation Number
379P
Lecture Time
12:00 - 12:00
Speakers
  • Shi Jie J. Lai (Tainan City, Taiwan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

380P - Clinico-pathological Features and Prognosis of Patients with Pregnancy Associated Breast Cancer – A Matched Case Control Study (ID 3705)

Presentation Number
380P
Lecture Time
12:00 - 12:00
Speakers
  • Ruyan Zhang (Beijing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

381TiP - TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (ID 1421)

Presentation Number
381TiP
Lecture Time
12:00 - 12:00
Speakers
  • Ahmad H. Awada (Brussels, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

382TiP - CONTESSA TRIO: A Multinational, Multicenter, Phase 2 Study of Tesetaxel plus 3 Different PD-(L)1 Inhibitors in Patients with Metastatic Triple-Negative Breast Cancer (TNBC) and Tesetaxel Monotherapy in Elderly Patients with HER2- Metastatic Breast Cancer (MBC) (ID 4119)

Presentation Number
382TiP
Lecture Time
12:00 - 12:00
Speakers
  • Sara M. Tolaney (Boston, MA, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

383TiP - Bintrafusp alfa (M7824) and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer (TNBC)(NCT03579472) (ID 4545)

Presentation Number
383TiP
Lecture Time
12:00 - 12:00
Speakers
  • Jennifer K. Litton (Houston, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

384TiP - Effectiveness of Olaparib Plus Trastuzumab in HER2[+], BRCA–mutated (BRCAm) or Homologous Recombination Deficient (HRD) Advanced Breast Cancer (ABC) patients (pts). The OPHELIA Study (ID 3340)

Presentation Number
384TiP
Lecture Time
12:00 - 12:00
Speakers
  • José Enrique Alés-Martínez (Ávila, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

385TiP - RIBOB : A Study on the efficacy and safety of Ribociclib in combination with letrozole in Older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced Breast cancer (aBC) with no prior systemic therapy for advanced disease (ID 1113)

Presentation Number
385TiP
Lecture Time
12:00 - 12:00
Speakers
  • Cindy Kenis (Leuven, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

386TiP - RIbociclib plus Goserelin with Hormonal Therapy versus physician Choice chemotherapy in premenopausal or perimenopausal patients with HR+, HER2– inoperable locally advanced or metastatic breast cancer – RIGHT Choice study (ID 4025)

Presentation Number
386TiP
Lecture Time
12:00 - 12:00
Speakers
  • Nagi S. El Saghir (Beirut, Lebanon)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

387TiP - Palbociclib Rechallenge in Hormone Receptor (HR)[+]/HER2[-] Advanced Breast Cancer (ABC). PALMIRA Trial (ID 3516)

Presentation Number
387TiP
Lecture Time
12:00 - 12:00
Speakers
  • Antonio Llombart Cussac (Lleida, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

388TiP - Alpelisib (ALP) + Endocrine Therapy (ET) by Last Prior Therapy in Patients (pts) With PIK3CA-Mutated Hormone-Receptor Positive (HR+) Human Epidermal Growth Factor Receptor-2-Negative (HER2–) Advanced Breast Cancer (ABC): Additional Study Cohort in BYLieve (ID 4616)

Presentation Number
388TiP
Lecture Time
12:00 - 12:00
Speakers
  • Eva Ciruelos (Madrid, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

389TiP - PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy. (ID 3592)

Presentation Number
389TiP
Lecture Time
12:00 - 12:00
Speakers
  • Tom Degenhardt (Munich, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

Gynaecological cancers (ID 6629)

Lecture Time
12:00 - 12:00
Speakers
  • Charlie Gourley (Edinburgh, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1000P - Efficacy and safety of oral poly (ADP-ribose) polymerase inhibitor fluzoparib in patients with BRCA1/2 mutations and platinum sensitive recurrent ovarian cancer (ID 4168)

Presentation Number
1000P
Lecture Time
12:00 - 12:00
Speakers
  • Ning Li (Beijing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1001P - Effect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase 3 study ARIEL3 of rucaparib maintenance treatment (ID 2785)

Presentation Number
1001P
Lecture Time
12:00 - 12:00
Speakers
  • Jonathan A. Ledermann (London, London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1002P - Integrated safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings (ID 3496)

Presentation Number
1002P
Lecture Time
12:00 - 12:00
Speakers
  • Rebecca Kristeleit (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1003P - Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers (ID 2844)

Presentation Number
1003P
Lecture Time
12:00 - 12:00
Speakers
  • S.Intidhar Labidi-Galy (Geneva, Switzerland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1004P - A Prospective Evaluation of Tolerability of Niraparib Dosing Based on Baseline Body Weight (BW) and Platelet (plt) Count: Blinded Pooled Interim Safety Data from the NORA Study (ID 1955)

Presentation Number
1004P
Lecture Time
12:00 - 12:00
Speakers
  • Xiaohua Wu (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1005P - Evaluation of Niraparib 200 mg/d as Maintenance Therapy in Recurrent Ovarian Cancer and Associated Thrombocytopenia in a Real-World US Setting (ID 2539)

Presentation Number
1005P
Lecture Time
12:00 - 12:00
Speakers
  • Premal Thaker (Saint Louis, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1006P - Niraparib initial dose and its’ management in patients with recurrent high-grade serous ovarian cancer. (ID 1290)

Presentation Number
1006P
Lecture Time
12:00 - 12:00
Speakers
  • Jacek P. Grabowski (Berlin, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1007P - Results of the 3rd interim analysis of C-Patrol: A non-interventional study on olaparib in German routine clinical practice (ID 3353)

Presentation Number
1007P
Lecture Time
12:00 - 12:00
Speakers
  • Jalid Sehouli (Berlin, Germany)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1008P - A real-world analysis of the treatment of advanced ovarian cancer with PARPIs (ID 740)

Presentation Number
1008P
Lecture Time
12:00 - 12:00
Speakers
  • Alejandra Martinez de Pinillos (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1009P - Incidence of tumour BRCA1/2 variants in relapsed, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer (ID 5867)

Presentation Number
1009P
Lecture Time
12:00 - 12:00
Speakers
  • Robert D. Morgan (Manchester, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1010P - Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among 882 high-risk individuals (ID 2966)

Presentation Number
1010P
Lecture Time
12:00 - 12:00
Speakers
  • Jihong Liu (Guangzhou, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1011P - BRCA testing of 1,284 Brazilian patients for hereditary breast and ovarian cancer in a routine diagnostic setting (ID 1687)

Presentation Number
1011P
Lecture Time
12:00 - 12:00
Speakers
  • Fernanda Milanezi (Sao Paulo, Brazil)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1012P - A multi-center integrative study on cancer predisposition genes in Chinese patients with epithelial ovarian carcinoma (ID 3162)

Presentation Number
1012P
Lecture Time
12:00 - 12:00
Speakers
  • Changbin Zhu (Shenzhen, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1013P - Incidental Early Occult Ovarian Cancer after Risk-Reducing Salpingo-Oophorectomy in BRCA1/2 Mutation Carriers followed in a Community Public Hospital (ID 5993)

Presentation Number
1013P
Lecture Time
12:00 - 12:00
Speakers
  • Begona Grana Suarez (A Coruña, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1014P - Response to chemotherapy in ovarian cancer (OC) patients with or without prior breast cancer (BC), stratified by BRCA mutation (BRCAm) status (ID 5334)

Presentation Number
1014P
Lecture Time
12:00 - 12:00
Speakers
  • Angela George (Sutton, Surrey, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1015P - Advanced ovarian cancer: is residual disease after debulking surgery affected by genetics factors involved in angiogenesis and immunity pathways? (ID 4565)

Presentation Number
1015P
Lecture Time
12:00 - 12:00
Speakers
  • Michele Bartoletti (Aviano, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1016P - Surrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study (ID 3251)

Presentation Number
1016P
Lecture Time
12:00 - 12:00
Speakers
  • Fabrice Lecuru (Paris, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1017P - Immune-Related Gene Expression Profiling after Neoadjuvant Chemotherapy (NACT) of Ovarian High-Grade Serous Carcinoma (ID 3278)

Presentation Number
1017P
Lecture Time
12:00 - 12:00
Speakers
  • Luis M. Manso (Madrid, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1018P - Tumor-infiltrating lymphocytes (TILs) in patients with epithelial ovarian cancer undergoing neoadjuvant chemotherapy: A restrospective study (ID 4906)

Presentation Number
1018P
Lecture Time
12:00 - 12:00
Speakers
  • Sara Giovannoni (Rome, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1019P - Prognostic significance of elements of the adaptive immunity in the microenvironment of epithelial ovarian cancer. (ID 3919)

Presentation Number
1019P
Lecture Time
12:00 - 12:00
Speakers
  • Periklis Foukas (Lausanne, Switzerland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1020P - Neutrophil-to-lymphocyte ratio predicts platinum sensitivity in epithelial ovarian cancer patients: a MITO24 retrospective study (ID 5139)

Presentation Number
1020P
Lecture Time
12:00 - 12:00
Speakers
  • Alberto Farolfi (Meldola, Forlì-Cesena, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1021P - The prognostic impact of monocyte to lymphocyte ratio (MLR) in advanced epithelial ovarian cancer (EOC) (ID 4212)

Presentation Number
1021P
Lecture Time
12:00 - 12:00
Speakers
  • Marc Cucurull Salamero (Badalona, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1022P - TP53 Hotspot mutations as immunoreactive neoantigens define a signature with differential survival outcomes in advanced ovarian cancer (ID 5123)

Presentation Number
1022P
Lecture Time
12:00 - 12:00
Speakers
  • Marica Garziera (Aviano, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1023P - Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients (ID 3795)

Presentation Number
1023P
Lecture Time
12:00 - 12:00
Speakers
  • Dominique Berton-Rigaud (Saint-Herblain, CEDEX, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1024P - Phase II study: Letrozole maintenance therapy after first line chemotherapy in patients with advanced serous and endometrioid ovarian cancer (ID 2359)

Presentation Number
1024P
Lecture Time
12:00 - 12:00
Speakers
  • Alexandra Tyulyandina (Moscow, Russian Federation)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1025P - Baseline IPI (Immune Prognostic Index) predicts survival in patients with advanced cervical cancer treated with immune checkpoint inhibitors (ICI). (ID 3619)

Presentation Number
1025P
Lecture Time
12:00 - 12:00
Speakers
  • Felix Blanc-Durand (Paris, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1026P - Preselecting tumor-infiltrating lymphocyte subsets to implement adoptive inmmunotherapy in ovarian cancer (ID 3474)

Presentation Number
1026P
Lecture Time
12:00 - 12:00
Speakers
  • Diego Salas-Benito (Pamplona, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1027P - Early prediction of the platinum-resistant relapse risk using the CA125 modeled kinetic parameter KELIM: a pooled analysis of AGO-OVAR 7 & 9; ICON 7 (AGO/GINECO/ MRC CTU/GCIG trials). (ID 5134)

Presentation Number
1027P
Lecture Time
12:00 - 12:00
Speakers
  • OLIVIER COLOMBAN (OULLINS, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1028P - Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a Phase 1b study in patients (pts) with ovarian cancer (ID 4410)

Presentation Number
1028P
Lecture Time
12:00 - 12:00
Speakers
  • David Omalley (Columbus, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1029P - Response to Pegylated Liposomal Doxorubicin (PLD) and Weekly Paclitaxel (wpac) in Platinum Resistant (PR) Ovarian Cancer (OC) by BRCA mutation status (ID 5077)

Presentation Number
1029P
Lecture Time
12:00 - 12:00
Speakers
  • Louise C. Bremer (Dunedin, New Zealand)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1030P - Impact of prior pegylated liposomal doxorubicin (PLD) treatment in recurrent ovarian cancer (ROC): Sub-group analysis from a randomized, open-label study comparing trabectedin (T) and PLD versus PLD alone in ROC (ET743-OVC-3006) (ID 3483)

Presentation Number
1030P
Lecture Time
12:00 - 12:00
Speakers
  • Bradley J. Monk (Phoenix, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1031P - OCTAVE - A phase I study of enadenotucirev, an oncolytic group B adenovirus, in combination with weekly paclitaxel in platinum-resistant epithelial ovarian cancer (ID 5423)

Presentation Number
1031P
Lecture Time
12:00 - 12:00
Speakers
  • Iain A. McNeish (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1032P - Phase I study of low dose whole abdominal radiation therapy (LDWART) in combination with weekly paclitaxel (wP) for platinum resistant ovarian cancer (PROC) (ID 1385)

Presentation Number
1032P
Lecture Time
12:00 - 12:00
Speakers
  • Natalie Y. Ngoi (Singapore, Singapore)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1033P - Phase 1b/2a study assessing the safety and efficacy of adding AL3818 (Anlotinib) to standard platinum-based chemotherapy in subjects with recurrent or metastatic endometrial, ovarian or cervical carcinoma (ID 2090)

Presentation Number
1033P
Lecture Time
12:00 - 12:00
Speakers
  • David Miller (San Francisco, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1034P - Phase I Study of Intraperitoneal TRX-E-002-1 in Subjects with Persistent or Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: Three-month Follow-up Results of the Dose Escalation Phase (ID 1960)

Presentation Number
1034P
Lecture Time
12:00 - 12:00
Speakers
  • Jermaine Coward (South Brisbane, Australia)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1035P - Hybrid capture-based genomic profiling of circulating tumor DNA (ctDNA) from patients with ovarian cancer (ID 4288)

Presentation Number
1035P
Lecture Time
12:00 - 12:00
Speakers
  • Mi Yang (Nanjing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1036P - Tumor Microvessel Density for predicting Nintedanib activity: data from the randomized CHIVA trial (a GINECO study) (ID 3433)

Presentation Number
1036P
Lecture Time
12:00 - 12:00
Speakers
  • Maud Villemin (Caen, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1037P - Post-hoc analysis of the nintedanib exposure-response relationships in the CHIVA trial in advanced ovarian cancer: (a GINECO study) (ID 3392)

Presentation Number
1037P
Lecture Time
12:00 - 12:00
Speakers
  • Skerdi HAVIARI (OULLINS, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1038P - The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian insufficiency in patient with malignant ovarian germ cell tumors (ID 714)

Presentation Number
1038P
Lecture Time
12:00 - 12:00
Speakers
  • Min Kyu Kim (Changwon, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1039P - Ex vivo cytotoxicity and in vivo antitumor activity of a novel highly selective STAT3 inhibitor YHO-1701 for ovarian and endometrial cancer (ID 1753)

Presentation Number
1039P
Lecture Time
12:00 - 12:00
Speakers
  • Kosei Hasegawa (Hidaka, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1040P - Mutational landscapes and tumor mutational burden expression in endometrial cancer (ID 3739)

Presentation Number
1040P
Lecture Time
12:00 - 12:00
Speakers
  • Yingli Zhang (Hangzhou, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1041P - Clinical features and frequency of mismatch repair protein deficiency in ovarian clear cell and endometrioid carcinoma patients. (ID 2109)

Presentation Number
1041P
Lecture Time
12:00 - 12:00
Speakers
  • Kazuhiro Takehara (Matsuyama, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1042P - Prospective study evaluating white adipose tissue inflammation and clinicopathologic features in endometrial cancer (ID 4554)

Presentation Number
1042P
Lecture Time
12:00 - 12:00
Speakers
  • Lea A. Moukarzel (New York City, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1043P - Cancer-specific survival with or without adjuvant chemotherapy in high-risk stage I endometrial cancer (ID 3645)

Presentation Number
1043P
Lecture Time
12:00 - 12:00
Speakers
  • Jenny Ko (Abbotsford, British Columbia, Canada)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1044P - Pembrolizumab in Patients with MSI-H Advanced Endometrial Cancer from the KEYNOTE-158 Study (ID 3394)

Presentation Number
1044P
Lecture Time
12:00 - 12:00
Speakers
  • David Omalley (Columbus, United States of America)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1045P - Who drops out of cervical cancer screening? Results from the EDIFICE 6 survey (ID 3388)

Presentation Number
1045P
Lecture Time
12:00 - 12:00
Speakers
  • Thibault De La Motte Rouge (Rennes, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1046P - Identification of a RNA-Seq Based Signature to Improve Prognostic for Uterine Sarcoma (ID 2485)

Presentation Number
1046P
Lecture Time
12:00 - 12:00
Speakers
  • Jian-Guo Zhou (Zunyi, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1047P - The Effect Of Multiple Interventions For Women At Risk For Cervical Cancer On Their Health Responsibility, Beliefs Regarding Cervical Cancer, And Having Screening: A Randomized Controlled Experiment (ID 1049)

Presentation Number
1047P
Lecture Time
12:00 - 12:00
Speakers
  • Busra Altinel (Konya, Turkey)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1048P - Quantifying the Effects of the Korean National Cancer Screening Program on Cervical Cancer Mortality (ID 1309)

Presentation Number
1048P
Lecture Time
12:00 - 12:00
Speakers
  • Nhung C. Bui (Goyang, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1049P - Spread of tumor and adverse events after modified radical hysterectomy for FIGO Stage IB1 cervical cancer patients with tumor diameter preoperatively estimated 2 cm or less: Japan Clinical Oncology Group trial (JCOG1101); exploratory analysis before primary analysis. (ID 1346)

Presentation Number
1049P
Lecture Time
12:00 - 12:00
Speakers
  • Takahide Arimoto (Minato-ku, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1050P - Impact of Combined Interstitial and Intracavitary Brachytherapy in locally advanced Cervical cancer: A Survival and toxicity profile assessment (ID 5352)

Presentation Number
1050P
Lecture Time
12:00 - 12:00
Speakers
  • Vibhay Pareek (Mumbai, India)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1051P - Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer (ID 2049)

Presentation Number
1051P
Lecture Time
12:00 - 12:00
Speakers
  • Chel Hun Choi (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1052P - Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274) (ID 1923)

Presentation Number
1052P
Lecture Time
12:00 - 12:00
Speakers
  • Linda R. Mileshkin (Melbourne, VIC, Australia)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1053P - Primary results from CECILIA, a global single-arm phase 2 study evaluating bevacizumab (BEV), carboplatin (C) and paclitaxel (P) for advanced cervical cancer (aCC) (ID 3284)

Presentation Number
1053P
Lecture Time
12:00 - 12:00
Speakers
  • Andres Redondo (Madrid, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1054P - Prognostic and clinicopathological significance of PD-L1 in patients with cervical cancer: a meta-analysis (ID 843)

Presentation Number
1054P
Lecture Time
12:00 - 12:00
Speakers
  • Xiaobin Gu (Zhengzhou, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1055P - Clinical impact of molecular profiling of cervical cancer (CC) patients (pts) in a dedicated Phase I (P1) unit (ID 1020)

Presentation Number
1055P
Lecture Time
12:00 - 12:00
Speakers
  • Mariana Scaranti (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1056P - Comparative proteomic profiles of cervical cancer and paried paracancerous tissue and the potential effects of DUSP7 over-expression through inhibiting RAS pathway on the biological characteristics of human cervical cancer cell line SIHA (ID 872)

Presentation Number
1056P
Lecture Time
12:00 - 12:00
Speakers
  • Xuan Jiang (Beijing, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1057P - Molecular profiling reveals novel targetable biomarkers in neuroendocrine carcinoma of the uterine cervix (ID 1988)

Presentation Number
1057P
Lecture Time
12:00 - 12:00
Speakers
  • Semir Vranic (Sarajevo, Bosnia and Herzegovina)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1058P - Changes in clinico-pathological characteristics of vulvar cancer in Japan: increasing oldest-old, stage-shifting, and decreasing cohort-level survival (ID 2672)

Presentation Number
1058P
Lecture Time
12:00 - 12:00
Speakers
  • Shin Nishio (Kurume, Fukuoka, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1059TiP - Tumor Treating Fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase 3 INNOVATE-3/ENGOT-ov50 study (ID 4306)

Presentation Number
1059TiP
Lecture Time
12:00 - 12:00
Speakers
  • Ignace B. Vergote (Leuven, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1060TiP - Randomized, phase 1b/2 study of M6620 + avelumab + carboplatin vs standard care (sc) in patients (pts) with platinum-sensitive poly (ADP-ribose) polymerase inhibitor-(PARPi)-resistant ovarian cancer (ID 5136)

Presentation Number
1060TiP
Lecture Time
12:00 - 12:00
Speakers
  • Susana Banerjee (London, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1061TiP - An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: A Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION (ID 2296)

Presentation Number
1061TiP
Lecture Time
12:00 - 12:00
Speakers
  • Jung-Yun Lee (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1062TiP - A phase 2 study of pembrolizumab in combination with doxorubicin in advanced, recurrent or metastatic endometrial cancer (ID 2732)

Presentation Number
1062TiP
Lecture Time
12:00 - 12:00
Speakers
  • Ana Oaknin (Barcelona, Spain)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1063TiP - ENGOT-EN9/LEAP-001: a phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer (ID 4404)

Presentation Number
1063TiP
Lecture Time
12:00 - 12:00
Speakers
  • Christian Marth (Innsbruck, Austria)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

1064TiP - Phase 1/2 trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8) (ID 4564)

Presentation Number
1064TiP
Lecture Time
12:00 - 12:00
Speakers
  • Ignace B. Vergote (Leuven, Belgium)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

Gastrointestinal tumours, colorectal (ID 6630)

Lecture Time
12:00 - 12:00
Speakers
  • Owen J. Sansom (Glasgow, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

534P - Updated data of Epitopes-HPV02 trial and external validation of efficacy of DCF in prospective Epitopes-HPV01 study in advanced anal squamous cell carcinoma. Pooled analysis of 115 patients (ID 4933)

Presentation Number
534P
Lecture Time
12:00 - 12:00
Speakers
  • Stefano Kim (Besançon, CEDEX, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

535P - Pre-specified pilot analysis of a randomised pilot/phase II/III trial comparing standard dose vs dose-escalated concurrent chemoradiotherapy (CRT) in anal cancer (PLATO-ACT5) (ID 2301)

Presentation Number
535P
Lecture Time
12:00 - 12:00
Speakers
  • Alexandra Gilbert (Leeds, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

536P - A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus. (ID 5773)

Presentation Number
536P
Lecture Time
12:00 - 12:00
Speakers
  • Rebecca Muirhead (Oxford, United Kingdom)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

537P - Timing to achieve complete response (CR) after definitive chemoradiotherapy (ChRT) in patients with squamous cell carcinoma of the anal (SCCAC) with and without HIV infection: a multicenter retrospective study (ID 4581)

Presentation Number
537P
Lecture Time
12:00 - 12:00
Speakers
  • Marcos P. Camandaroba (Sao Paulo, Brazil)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

538P - Planned organ preservation for T2 T3 M0 rectal adenocarcinoma. A possible option using chemoradiotherapy (CRT) and Contact X-ray Brachytherapy (CXB). A French multicenter study. (ID 1712)

Presentation Number
538P
Lecture Time
12:00 - 12:00
Speakers
  • Jean-Pierre Gérard (Nice, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

539P - Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: A pooled analysis of 5491 patients (ID 1241)

Presentation Number
539P
Lecture Time
12:00 - 12:00
Speakers
  • San-Jun Cai (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

540P - A Phase 1b Study of E7046 (AN0025) in Combination With Radiotherapy/Chemoradiotherapy (RT/CRT) in Preoperative Treatment of Rectal Cancer (ID 4639)

Presentation Number
540P
Lecture Time
12:00 - 12:00
Speakers
  • Lucjan Wyrwicz (Warsaw, Poland)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

541P - Upfront radical surgery with total mesorectal excision (TME) versus preoperative chemoradiotherapy followed by TME in clinical stage II/III patients with rectal cancer: a propensity score analysis (ID 2310)

Presentation Number
541P
Lecture Time
12:00 - 12:00
Speakers
  • Ahrong Ham (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

542P - Neoadjuvant chemoradiotherapy with/without lateral lymph node dissection for low rectal cancer: Which patients can benefit? (ID 2747)

Presentation Number
542P
Lecture Time
12:00 - 12:00
Speakers
  • Daisuke Nishizaki (Kyoto, Japan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

543P - The impact of completeness of chemotherapy on the efficacy of irinotecan in the preoperative chemoradiotherapy of locally advanced rectal cancer. (ID 2877)

Presentation Number
543P
Lecture Time
12:00 - 12:00
Speakers
  • Jingwen Wang (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

544P - Feasibility of robot-assisted surgery in elderly patients with rectal cancer (ID 3050)

Presentation Number
544P
Lecture Time
12:00 - 12:00
Speakers
  • Wei-Chih Su (Kaohsiung City, Taiwan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

545P - Feasibility of chemoradiotherapy in rectal cancer patients with peritumoral abscesses and fistulas: a case-control non-inferiority trial (ID 4109)

Presentation Number
545P
Lecture Time
12:00 - 12:00
Speakers
  • Valerii Ivanov (Moscow, Russian Federation)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

546P - Differential of the nutritional index before and after neoadjuvant chemoradiotherapy as a prognostic factor of recurrence in patients with locally advanced adenocarcinoma of the rectum (ID 4813)

Presentation Number
546P
Lecture Time
12:00 - 12:00
Speakers
  • Leslie Navia-Ortuño (Ciudad de Mexico, Mexico)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

547P - Short-term Clinical Outcomes of Robotic-Assisted Total Mesorectal Excision in Rectal Cancer after concurrent chemoradiotherapy (ID 5345)

Presentation Number
547P
Lecture Time
12:00 - 12:00
Speakers
  • Pojung Chen (Kaohsiung City, Taiwan)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

548P - Local immune status in cancer cell nests can be a predictor of survival for rectal cancer with neoadjuvant radiotherapy (ID 5489)

Presentation Number
548P
Lecture Time
12:00 - 12:00
Speakers
  • Xijin Lin (Fuzhou,Fujian, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

549P - Impact of concomitant medications on disease free survival (DFS) and overall survival (OS) in patients from the PETACC8 study. (ID 1653)

Presentation Number
549P
Lecture Time
12:00 - 12:00
Speakers
  • Clémence Brun (Dijon, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

550P - Updated results of NORDIC 8, a randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer. (ID 5206)

Presentation Number
550P
Lecture Time
12:00 - 12:00
Speakers
  • Per Pfeiffer (Odense C, Denmark)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

551P - Clinical impact of mucinous and poorly differentiated tumors on the outcome of patients with stage II colon cancer: a TOSCA subgroup analysis (ID 2992)

Presentation Number
551P
Lecture Time
12:00 - 12:00
Speakers
  • Gerardo Rosati (Potenza, Italy)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

552P - Exercise improved adjuvant treatment completion rates and treatment-related toxicities in colorectal cancer: A prospective pilot study (ID 4753)

Presentation Number
552P
Lecture Time
12:00 - 12:00
Speakers
  • Hong Jun Kim (Seoul, Korea, Republic of)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

553P - Bevacizumab plus Oxaliplatin-Based Chemotherapy as Adjuvant Treatment for Colon Cancer (CC): Updated analysis of stage II disease from the AVANT Phase III Randomized trial by the GERCOR Group (ID 2735)

Presentation Number
553P
Lecture Time
12:00 - 12:00
Speakers
  • Aimery De Gramont (Levallois Perret, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

554P - Multicenter Validation of the Postoperative Carcinoembryonic Antigen Combined Prognostic Model for Stage Ⅲ Colon Cancer (ID 1843)

Presentation Number
554P
Lecture Time
12:00 - 12:00
Speakers
  • Ji Zhu (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

555P - Impact of the IDEA study on clinical practice for stage III colon cancer patients: a French GERCOR - FFCD - GI UNICANCER national survey. (ID 2554)

Presentation Number
555P
Lecture Time
12:00 - 12:00
Speakers
  • Kaissa Ouali (Paris, France)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

556P - Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer (ID 3285)

Presentation Number
556P
Lecture Time
12:00 - 12:00
Speakers
  • Philip Falk (Lund, Sweden)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

557P - Loss of CDX-2 expression is an independent poor prognostic biomarker in colorectal cancer (ID 3905)

Presentation Number
557P
Lecture Time
12:00 - 12:00
Speakers
  • Krittiya Korphaisarn (Pathumwan, Thailand)
Session Name
Poster Display session
Location
Poster Area (Hall 4), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
12:00 - 13:00
Poster Display session Poster Display session

558P - Robot-assisted natural orifice specimen extraction surgery for radical resection of colorectal cancer (ID 3963)

Presentation Number
558P
Lecture Time
12:00 - 12:00
Speakers
  • Zhengchuan Niu (Shanghai, China)
Session Name
Poster Display session
Location
Poster Area